BLINKLAB Limited has joined the MAGNET (Monash Autism & ADHD Genetics and Neurodevelopment) study, led by the university's School of Psychological Sciences.
The study, which aims to enrol 1,000 families with children diagnosed with autism, ADHD, or both, seeks to identify new autism and ADHD subtypes using deep phenotype data.
BlinkLab's Dx 1 biomarkers, including the Prepulse Inhibition (PPI) measure, will play a key role in differentiating between autism and ADHD - see more, HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Nov 24
